Cartesian Therapeutics
RNAC
RNAC
95 hedge funds and large institutions have $154M invested in Cartesian Therapeutics in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.35% less ownership
Funds ownership: 1.91% → 1.56% (-0.35%)
37% less call options, than puts
Call options by funds: $353K | Put options by funds: $564K
Holders
95
Holding in Top 10
1
Calls
$353K
Puts
$564K
Top Buyers
| 1 | +$4.96M | |
| 2 | +$3.96M | |
| 3 | +$3.21M | |
| 4 |
Two Sigma Investments
New York
|
+$2.82M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.68M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$15.4M | |
| 3 | -$5.86M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.13M |
| 5 |
O
OrbiMed
New York
|
-$4.71M |